4DMedical Limited
ASX: 4DX.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Andreas Fouras
- Employees
- 145
- Headquarters
- Carlton, Australia
- IPO year
- 2020
- Market cap
- A$1.9B
- Website
- https://www.4dmedical.com
Loading 4DX…
Loading profile data…Frequently asked questions about 4DX
What does 4DMedical Limited (4DX.AX) do?
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in...
Where does 4DX.AX trade?
4DMedical Limited (4DX.AX) trades on the Australian Securities Exchange.
What sector is 4DX.AX in?
4DMedical Limited (4DX.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of 4DMedical Limited?
Andreas Fouras is the chief executive officer of 4DMedical Limited (4DX.AX).
Where is 4DMedical Limited headquartered?
4DMedical Limited is headquartered in Australia.
Does 4DX.AX pay a dividend?
4DMedical Limited (4DX.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4DX.AX go public?
4DMedical Limited (4DX.AX) completed its initial public offering in 2020.